세계의 각막이식 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Corneal Transplant was estimated to be worth US$ 1538 million in 2024 and is forecast to a readjusted size of US$ 2287 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Corneal Transplant (keratoplasty) is a common transplantation procedure with a very high success rate. A scarred, severely painful, perforated, deformed or cloudy cornea (the clear layer in front of the iris and pupil) can be replaced with a clear, healthy cornea.

The donated cornea comes from a recently deceased person. Tissue matching is not routinely required because rejection is relatively rare and can usually be treated (see Complications of corneal transplantation). Transplantation is most likely to be successful when it is performed for diseases such as bullous keratopathy, keratoconus and certain corneal scars.

In a broad sense, corneal transplantation refers to replacing cloudy and diseased corneal tissue with foreign materials to achieve the purpose of restoring the patient's vision or controlling corneal diseases and beauty. Therefore, it includes allogeneic corneal transplantation, xenogeneic corneal transplantation, autologous corneal transplantation, tissue-engineered corneal transplantation and artificial corneal transplantation. Corneal transplantation usually refers to allogeneic corneal transplantation, which is to use normal corneal tissue of a foreign body to replace cloudy or diseased corneal tissue to restore vision or control corneal lesions. It is the one with the highest success rate among allogeneic organ transplants and one of the important eye restoration surgeries. The scope of this report is the various expenses incurred during corneal transplantation, including surgical expenses, consumables, cornea, anesthetic drugs, and various disposal costs during the treatment process.

Aging populations in developed and emerging economies lead to higher rates of corneal degeneration and diseases.

Age-related corneal endothelial failure (Fuchs' dystrophy) is one of the common indications for endothelial keratoplasty.

Advancements in Surgical Techniques

Minimally invasive techniques like DALK, DSEK, and DMEK offer faster recovery, better visual outcomes, and lower rejection rates compared to traditional PK.

The adoption of femtosecond lasers for precise cuts and better graft alignment has improved surgical success rates.

Expansion of Eye Banks and Donor Programs

Improved awareness campaigns and government initiatives have increased corneal tissue donations in many countries.

Technological progress in cornea preservation (e.g., hypothermic storage, organ culture) extends tissue shelf-life and facilitates international tissue exchange.

Increasing Healthcare Expenditure & Insurance Coverage

Rising disposable income, better access to healthcare services, and broader insurance coverage in developing economies boost the affordability of advanced eye surgeries.

Non-profit organizations and international collaborations provide support for surgeries in low-resource settings.

Innovation in Artificial Corneas (Keratoprostheses)

For patients unsuitable for traditional donor grafts or repeat graft failure, keratoprostheses (e.g., Boston KPro) offer hope.

Advances in biocompatible materials and design improve long-term outcomes for severe cases.

This report aims to provide a comprehensive presentation of the global market for Corneal Transplant, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Corneal Transplant by region & country, by Type, and by Application.

The Corneal Transplant market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corneal Transplant.

Market Segmentation

By Company

• CryoLife, Inc.
• Exactech, Inc.
• Kohler GmbH
• Lifeline Scientific
• LIFECELL CORPORATION
• Medtronic

Segment by Type

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty
• Corneal Limbal Stem Cell Transplant
• Others

Segment by Application

• Hospital
• Eye Clinics
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Corneal Transplant company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Corneal Transplant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Corneal Transplant in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Corneal Transplant Product Introduction
• 1.2 Global Corneal Transplant Market Size Forecast (2020-2031)
• 1.3 Corneal Transplant Market Trends & Drivers
  • 1.3.1 Corneal Transplant Industry Trends
  • 1.3.2 Corneal Transplant Market Drivers & Opportunity
  • 1.3.3 Corneal Transplant Market Challenges
  • 1.3.4 Corneal Transplant Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Corneal Transplant Players Revenue Ranking (2024)
• 2.2 Global Corneal Transplant Revenue by Company (2020-2025)
• 2.3 Key Companies Corneal Transplant Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Corneal Transplant Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Corneal Transplant
• 2.6 Corneal Transplant Market Competitive Analysis
  • 2.6.1 Corneal Transplant Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Corneal Transplant Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corneal Transplant as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Penetrating Keratoplasty
  • 3.1.2 Endothelial Keratoplasty
  • 3.1.3 Descemet Stripping Automated Endothelial Keratoplasty
  • 3.1.4 Corneal Limbal Stem Cell Transplant
  • 3.1.5 Others
• 3.2 Global Corneal Transplant Sales Value by Type
  • 3.2.1 Global Corneal Transplant Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Corneal Transplant Sales Value, by Type (2020-2031)
  • 3.2.3 Global Corneal Transplant Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Eye Clinics
  • 4.1.3 Others
• 4.2 Global Corneal Transplant Sales Value by Application
  • 4.2.1 Global Corneal Transplant Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Corneal Transplant Sales Value, by Application (2020-2031)
  • 4.2.3 Global Corneal Transplant Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Corneal Transplant Sales Value by Region
  • 5.1.1 Global Corneal Transplant Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Corneal Transplant Sales Value by Region (2020-2025)
  • 5.1.3 Global Corneal Transplant Sales Value by Region (2026-2031)
  • 5.1.4 Global Corneal Transplant Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Corneal Transplant Sales Value, 2020-2031
  • 5.2.2 North America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Corneal Transplant Sales Value, 2020-2031
  • 5.3.2 Europe Corneal Transplant Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Corneal Transplant Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Corneal Transplant Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Corneal Transplant Sales Value, 2020-2031
  • 5.5.2 South America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Corneal Transplant Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Corneal Transplant Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Corneal Transplant Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Corneal Transplant Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Corneal Transplant Sales Value, 2020-2031
  • 6.3.2 United States Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Corneal Transplant Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Corneal Transplant Sales Value, 2020-2031
  • 6.4.2 Europe Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Corneal Transplant Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Corneal Transplant Sales Value, 2020-2031
  • 6.5.2 China Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Corneal Transplant Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Corneal Transplant Sales Value, 2020-2031
  • 6.6.2 Japan Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Corneal Transplant Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Corneal Transplant Sales Value, 2020-2031
  • 6.7.2 South Korea Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Corneal Transplant Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Corneal Transplant Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Corneal Transplant Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Corneal Transplant Sales Value, 2020-2031
  • 6.9.2 India Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Corneal Transplant Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 CryoLife, Inc.
  • 7.1.1 CryoLife, Inc. Profile
  • 7.1.2 CryoLife, Inc. Main Business
  • 7.1.3 CryoLife, Inc. Corneal Transplant Products, Services and Solutions
  • 7.1.4 CryoLife, Inc. Corneal Transplant Revenue (US$ Million) & (2020-2025)
  • 7.1.5 CryoLife, Inc. Recent Developments
• 7.2 Exactech, Inc.
  • 7.2.1 Exactech, Inc. Profile
  • 7.2.2 Exactech, Inc. Main Business
  • 7.2.3 Exactech, Inc. Corneal Transplant Products, Services and Solutions
  • 7.2.4 Exactech, Inc. Corneal Transplant Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Exactech, Inc. Recent Developments
• 7.3 Kohler GmbH
  • 7.3.1 Kohler GmbH Profile
  • 7.3.2 Kohler GmbH Main Business
  • 7.3.3 Kohler GmbH Corneal Transplant Products, Services and Solutions
  • 7.3.4 Kohler GmbH Corneal Transplant Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Kohler GmbH Recent Developments
• 7.4 Lifeline Scientific
  • 7.4.1 Lifeline Scientific Profile
  • 7.4.2 Lifeline Scientific Main Business
  • 7.4.3 Lifeline Scientific Corneal Transplant Products, Services and Solutions
  • 7.4.4 Lifeline Scientific Corneal Transplant Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Lifeline Scientific Recent Developments
• 7.5 LIFECELL CORPORATION
  • 7.5.1 LIFECELL CORPORATION Profile
  • 7.5.2 LIFECELL CORPORATION Main Business
  • 7.5.3 LIFECELL CORPORATION Corneal Transplant Products, Services and Solutions
  • 7.5.4 LIFECELL CORPORATION Corneal Transplant Revenue (US$ Million) & (2020-2025)
  • 7.5.5 LIFECELL CORPORATION Recent Developments
• 7.6 Medtronic
  • 7.6.1 Medtronic Profile
  • 7.6.2 Medtronic Main Business
  • 7.6.3 Medtronic Corneal Transplant Products, Services and Solutions
  • 7.6.4 Medtronic Corneal Transplant Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Medtronic Recent Developments

8 Industry Chain Analysis

• 8.1 Corneal Transplant Industrial Chain
• 8.2 Corneal Transplant Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Corneal Transplant Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Corneal Transplant Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer